FR2509175B1 - Preparation therapeutique ayant d'excellentes proprietes d'absorption - Google Patents

Preparation therapeutique ayant d'excellentes proprietes d'absorption

Info

Publication number
FR2509175B1
FR2509175B1 FR8203123A FR8203123A FR2509175B1 FR 2509175 B1 FR2509175 B1 FR 2509175B1 FR 8203123 A FR8203123 A FR 8203123A FR 8203123 A FR8203123 A FR 8203123A FR 2509175 B1 FR2509175 B1 FR 2509175B1
Authority
FR
France
Prior art keywords
absorption properties
excellent absorption
therapeutic preparation
therapeutic
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8203123A
Other languages
English (en)
French (fr)
Other versions
FR2509175A1 (fr
Inventor
Masataka Morishita
Renji Aikawa
Shigeo Katsuragi
Yoshiaki Yamamoto
Kenichi Sugimoto
Kazuyoshi Nishiie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Jozo KK
Original Assignee
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3270581A external-priority patent/JPS57146721A/ja
Priority claimed from JP57004222A external-priority patent/JPS58140026A/ja
Application filed by Toyo Jozo KK filed Critical Toyo Jozo KK
Publication of FR2509175A1 publication Critical patent/FR2509175A1/fr
Application granted granted Critical
Publication of FR2509175B1 publication Critical patent/FR2509175B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR8203123A 1981-03-06 1982-02-25 Preparation therapeutique ayant d'excellentes proprietes d'absorption Expired FR2509175B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3270581A JPS57146721A (en) 1981-03-06 1981-03-06 Improver for absorption
JP57004222A JPS58140026A (ja) 1982-01-14 1982-01-14 吸収性良好な製剤

Publications (2)

Publication Number Publication Date
FR2509175A1 FR2509175A1 (fr) 1983-01-14
FR2509175B1 true FR2509175B1 (fr) 1987-01-16

Family

ID=26337952

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8203123A Expired FR2509175B1 (fr) 1981-03-06 1982-02-25 Preparation therapeutique ayant d'excellentes proprietes d'absorption

Country Status (4)

Country Link
CA (1) CA1188987A (enrdf_load_stackoverflow)
DE (1) DE3207480A1 (enrdf_load_stackoverflow)
FR (1) FR2509175B1 (enrdf_load_stackoverflow)
GB (1) GB2095994B (enrdf_load_stackoverflow)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093551B1 (en) * 1982-04-30 1991-01-16 Ajinomoto Co., Inc. Pharmaceutical composition
US4731360A (en) * 1985-08-16 1988-03-15 Merck & Co., Inc. Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
US4692441A (en) * 1985-08-16 1987-09-08 Merck & Co., Inc. Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities
DE3726324A1 (de) * 1987-08-07 1989-02-16 Hoechst Ag Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
DD293488A5 (de) * 1989-02-22 1991-09-05 Berlin-Chemie Ag, Verfahren zur herstellung von arzneimitteln zur rektalen applikation
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US6331318B1 (en) 1994-09-30 2001-12-18 Emisphere Technologies Inc. Carbon-substituted diketopiperazine delivery systems
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5578323A (en) 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US6099856A (en) 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
WO1994023767A1 (en) * 1993-04-22 1994-10-27 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5693338A (en) 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
FR2676922B1 (fr) * 1991-06-03 1995-01-20 Givaudan Lavirotte Applications en cosmetique de derives n-acyles de melanges d'acides amines issus d'hydrolysats de proteines vegetales.
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5811127A (en) 1992-06-15 1998-09-22 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5401516A (en) 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US20010003001A1 (en) 1993-04-22 2001-06-07 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5709861A (en) 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5958457A (en) 1993-04-22 1999-09-28 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US6461643B2 (en) 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
CA2164957A1 (en) * 1993-06-14 1994-12-22 Sam J. Milstein Protenoid carriers and methods for preparation and use thereof
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CN1151836C (zh) 1995-03-31 2004-06-02 艾米斯菲尔技术有限公司 用作传送活性剂的化合物和组合物
US6090958A (en) 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5965121A (en) 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5989539A (en) 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5820881A (en) 1995-04-28 1998-10-13 Emisphere Technologies, Inc. Microspheres of diamide-dicarboxylic acids
US5824345A (en) 1995-06-07 1998-10-20 Emisphere Technologies, Inc. Fragrances and flavorants
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US5667806A (en) 1995-06-07 1997-09-16 Emisphere Technologies, Inc. Spray drying method and apparatus
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
GB2320248B (en) 1995-09-11 1999-04-14 Emisphere Tech Inc Method for preparing omega-aminoalkanoic acid derivatives from cycloalkanones
IL126318A (en) 1996-03-29 2004-09-27 Emisphere Tech Inc Compounds and compositions for delivering active agents and some novel carrier compounds
EP0904065A4 (en) 1996-06-14 2000-06-14 Emisphere Tech Inc MICRO-ENCLOSED FRAGRANCES AND PRODUCTION METHOD
US6391303B1 (en) 1996-11-18 2002-05-21 Emisphere Technologies, Inc. Methods and compositions for inducing oral tolerance in mammals
US5990166A (en) 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6313088B1 (en) 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US5804688A (en) 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5879681A (en) 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US5939381A (en) 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5876710A (en) 1997-02-07 1999-03-02 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6060513A (en) 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5863944A (en) 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5962710A (en) 1997-05-09 1999-10-05 Emisphere Technologies, Inc. Method of preparing salicyloylamino acids
ATE295347T1 (de) 1998-07-27 2005-05-15 Emisphere Tech Inc Stoffe und zusammensetzungen für die verabreichung aktiver substanzen
US6440929B1 (en) 1998-07-27 2002-08-27 Emisphere Technologies, Inc. Pulmonary delivery of active agents
KR100659753B1 (ko) 1998-08-07 2006-12-20 에미스페어 테크놀로지스, 인코포레이티드 활성제 전달용 화합물 및 조성물
US6991798B1 (en) 1998-08-07 2006-01-31 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
EP1146860A4 (en) 1999-01-08 2002-07-03 Emisphere Tech Inc POLYMER DRUG DELIVERY SYSTEMS AND COMPOUNDS
US7084279B1 (en) 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
NZ534409A (en) 1999-04-05 2006-03-31 Emisphere Tech Inc Disodium salts, monohydrates, and ethanol solvates for delivering active agents
US7129274B1 (en) 1999-11-05 2006-10-31 Emisphere Technologies Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
US7279597B1 (en) 1999-11-05 2007-10-09 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
ES2298168T3 (es) 1999-12-16 2008-05-16 Emisphere Technologies, Inc. Compuestos y composiciones para suministrar agentes activos.
AU2001236457A1 (en) 2000-01-13 2001-07-24 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
DE60133555T2 (de) 2000-06-29 2008-09-18 Emisphere Technologies, Inc. Verbindungen und gemische zur verabreichung eines aktiven agens
EP2067482B1 (en) 2006-09-27 2012-11-28 Asahi Kasei Pharma Corporation Calcitonins for preventing development of reflex sympathetic dystrophy after stroke
ES2616004T3 (es) 2009-11-18 2017-06-09 Asahi Kasei Pharma Corporation Agente profiláctico y/o agente terapéutico y/o agente supresor de exacerbación para osteortritis de rodilla humana
IL238101A (en) * 2015-04-01 2017-01-31 Neodel Tec Ltd Method for making n - noble peptides, polypeptides and proteins
US20200268821A1 (en) * 2017-10-05 2020-08-27 Receptor Holdings, Inc. Herbal compositions with improved bioavailability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470M (fr) * 1962-03-13 1964-04-20 Mead Johnson & Co Composition thérapeutique.
GB1294664A (en) * 1968-12-31 1972-11-01 Unilever Ltd Modified proteins
FR2074632B1 (enrdf_load_stackoverflow) * 1970-01-13 1973-01-12 Roussel Uclaf
GB1485694A (en) * 1975-01-22 1977-09-14 Ajinomoto Kk Gelling agents
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
US4436726A (en) * 1980-12-15 1984-03-13 Fujisawa Pharmaceutical Co., Ltd. N-Acylpeptide compound, processes for the preparation thereof and the pharmaceutical compositions

Also Published As

Publication number Publication date
GB2095994A (en) 1982-10-13
DE3207480A1 (de) 1982-10-07
GB2095994B (en) 1985-10-02
CA1188987A (en) 1985-06-18
FR2509175A1 (fr) 1983-01-14
DE3207480C2 (enrdf_load_stackoverflow) 1991-06-06

Similar Documents

Publication Publication Date Title
FR2509175B1 (fr) Preparation therapeutique ayant d'excellentes proprietes d'absorption
FR2487349B1 (fr) Derives de l'hydronaphtalene, leur preparation et leur utilisation en therapeutique
IT1148006B (it) Ammidi dotate di proprieta' farmaceutiche e loro preparazione
IT1150622B (it) Polisaccaridi dotati di attivita' ant-carcinogena e procedimento per la loro preparazione
FR2497669B1 (fr) Preparation pharmaceutique ayant d'excellentes proprietes d'absorption
KR900007411A (ko) Nb-818의 용이흡수성 약제
IT1157217B (it) Procedimento e dispositivo per l'ossigenazione del sangue
KR890701004A (ko) 개선된 생리효과를 가지는 식물의 제조 및 이 식물의 용도
IT1223529B (it) Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse
MA19965A1 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
FR2544309B1 (fr) Diphenylazomethines hydroxylees, leur preparation et leur application en therapeutique
ES516534A0 (es) "procedimiento de preparacion de 2-isopropilamino-pirimidina-n-oxido".
ES263793Y (es) "almohadon terapeutico".
IT8529517V0 (it) Guida audiofonica alla citta'
ES259928Y (es) Audiometro infantil
KR880001256U (ko) 키타의 전음 장치
KR880005158U (ko) Vtr의 폴 베이스 습동장치
FI940103L (fi) 2',3'-deoksi-2',3'-didehydronukleosidien valmistus
SE8404465D0 (sv) Medical preparation
IT1178208B (it) Pannolini monouso aventi migliorate proprieta' di assorbimento
FR2612241B1 (fr) Coffre-fort d'appartement
CA44202S (en) Invalid's chair
ES280318Y (es) Sillon infantil
ES260515Y (es) Cantimplora infantil
FR2547582B1 (fr) 3-aminomethyl-5-methyl-1,4 dioxannes substitues, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse